The present study tests the hypothesis that dual deletion of AT 1a receptors and NHE3 selectively in the proximal tubules further attenuates angiotensin II (Ang II)-induced and two-kidney, one-clip (2K1C) Goldblatt Hypertension. Proximal tubule (PT)-specific AT 1a receptor and NHE3 double knockout mice, PT- Agtr1a -/- /Nhe3 -/- , were generated using the iL- Sglt2-Cre/LoxP approach. Male and female wild-type (WT) and PT- Agtr1a -/- /Nhe3 -/- double knockout mice were infused with a pressor dose of Ang II for 2 weeks (1.5 mg/kg body wt./day, i.p.) or induced with 2K1C Goldblatt hypertension for 4 weeks. In WT mice, basal systolic blood pressure (SBP) was 118 ± 3 mmHg (n=9), which increased to 161 ± 3 mmHg in response to Ang II infusion ( P<0.01, n=10) or to 136 ± 3 in response to induction of 2K1C Goldblatt hypertension (n=12, P<0.01). By comparison, basal SBP was 13 ± 2 mmHg lower in PT- Agtr1a -/- ( P<0.01) or in PT- Nhe3 -/- single gene knockout mice than WT mice ( P<0.01). Double deletion of AT 1a and NHE3 in the proximal tubules further lowered basal SBP by 6 ± 2 mmHg in PT- Agtr1a -/- /Nhe3 -/- mice ( P<0.05). In response to Ang II infusion, SBP increased to 121 ± 3 mmHg in PT- Agtr1a -/- /PT-Nhe3 -/- mice ( P <0.01). 2K1C Goldblatt hypertension was attenuated in PT- Agtr1a -/- (108 ± 3 mmHg, P<0.01, n=10), PT- Nhe3 -/- (110 ± 2 mmHg, P<0.01, n=10), or PT- Agtr1a -/- /Nhe3 -/- mice (103 ± 2 mmHg, P<0.01, n=8), respectively. Taken together, our study provides further evidence for a key role of proximal tubule AT 1a receptors and NHE3 in the development of Ang II-induced and 2K1C Goldblatt hypertension.
Building similarity graph...
Analyzing shared references across papers
Loading...
Xiao‐Chun Li
Tulane University
Rumana Hassan
Tulane University
Jia L. Zhuo
Tulane University
AJP Renal Physiology
Tulane University
Building similarity graph...
Analyzing shared references across papers
Loading...
Li et al. (Tue,) studied this question.
synapsesocial.com/papers/68d6cd68b1249cec298b3a82 — DOI: https://doi.org/10.1152/ajprenal.00122.2025